Savaysa: Indications, Dosage, Precautions, Adverse Effects
Россия
  • Россия
  • Украина

Manufacture: Daiichi Sankyo, Inc.
Country: United States
Condition: Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Prevention of Thromboembolism in Atrial Fibrillation
Class: Factor Xa inhibitors
Form: Tablets
Ingredients: edoxaban tosylate monohydrate, mannitol, pregelatinized starch, crospovidone, hydroxypropyl cellulose, magnesium stearate, talc, carnauba wax; hypromellose, titanium dioxide, talc, polyethylene glycol 8000, iron oxide yellow (15 mg tablets and 60 mg tablets), iron oxide red (15 mg tablets and 30 mg tablets)